Clinical Value of DWI-ADC Matching in the Short-term Prognosis of Wilson's Disease
Conditions: Hepatolenticular Degeneration; Wilson Sponsors: Hospital Affiliated to the Institute of Neurology, Anhui University of Chinese Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
Evaluation of Cognitive Dysfunction and Psychiatric Comorbidities
Conditions: Wilson Disease Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2023 Category: Research Source Type: clinical trials
Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior ® (450mg Trientine Base, Twice Daily).
Conditions: Wilson ' s Disease Interventions: Drug: 900mg TETA 4HCl Once Daily Formulation; Drug: 900mg TETA 4HCl Cuprior ® Sponsors: Orphalan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
Early Detection of Cardiac Affection in Patients of Wilson's Disease
Conditions: Cardiovascular Diseases; Wilson's Disease Intervention: Sponsor: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
Early Detection of Cardiac Affection in Patients of Wilson's Disease
Conditions: Cardiovascular Diseases; Wilson ' s Disease Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
Performance and Safety of MEX-CD1 Low-volume Continuous Veno-venous Haemodialysis Medical Device for Copper-extraction in Patients With Wilson's Disease Patients
Condition: Hepatolenticular Degeneration; Wilson Intervention: Device: Low-volume continuous veno-venous haemodialysis Sponsors: Mexbrain; ISS AG Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2023 Category: Research Source Type: clinical trials
Performance and Safety of MEX-CD1 Low-volume Continuous Veno-venous Haemodialysis Medical Device for Copper-extraction in Patients With Wilson's Disease Patients
Condition: Hepatolenticular Degeneration; Wilson Intervention: Device: Low-volume continuous veno-venous haemodialysis Sponsors: Mexbrain; Integrated Scientific Services (ISS) AG Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2023 Category: Research Source Type: clinical trials
